U.S. FDA Clears MedCognetics’ AI Enabled Breast Cancer Screening Software
Digital Health Software Platform Reduces Time and Cost of Imaging and Improves Outcomes Across Diverse Patient Populations DALLAS--(BUSINESS WIRE)--#AI--MedCognetics, Inc. today announced it has received U.S Food and Drug Administration (FDA) 510(k) c...